Topics
CNS Tumors | Treatment | Targeted therapy | Afatinib
Home > Publications > Topics > CNS Tumors > Treatment > Targeted therapy > Afatinib
Juarez TM, Gill JM, Heng A, Carrillo JA, Wagle N, Nomura N, Nguyen
M, Truong J, Dobrawa L, Sivakumar W, Barkhoudarian G, Kelly DF,
Kesari S.
A phase I dose-escalation
study of pulsatile afatinib in patients with recurrent or
progressive brain cancer.
Neurooncol
Adv. 2024 Mar 30;6(1):vdae049. doi:
10.1093/noajnl/vdae049. PMID:
38680990. Interventional study. ˍ